Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.
Read Full NewsA phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.
Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.
Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.
A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.
Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.
Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.
Research is limited, but what has been done shows a possible connection.
1.
Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes
2.
A computer-aided diagnostic system for improved detection of breast cancer.
3.
Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.
4.
Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'
5.
According to JAMA, statin use may increase cancer-related survival in breast cancer patients.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
3.
Anesthetic Techniques and Strategies in Cancer Surgery: Unveiling the Impact on Oncological Outcomes
4.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
5.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge